Submicroscopic deletions in 5q- associated malignancies

Haematologica

Volumn 89, Issue 3, 2004, Pages 281-285

  Crescenzi, Barbara ^a   La Starza, Roberta ^a   Romoli, Silvia ^a   Beacci, Donatella ^a   Matteucci, Caterina ^a   Barba, Gianluca ^a   Aventin, Ana ^b   Marynen, Peter ^c   Ciolli, Stefania ^d   Nozzoli, Chiara ^d   Martelli, Massimo Fabrizio ^a   Mecucci, Cristina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

5q ; Complex karyotype; Microdeletions

Indexed keywords

PROTEIN P53; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHROMOSOME 5; CHROMOSOME DELETION 5; CLINICAL ARTICLE; CYTOGENETICS; DISEASE ASSOCIATION; FEMALE; HUMAN; IN SITU HYBRIDIZATION; INTERPHASE; KARYOTYPE; MALE; METAPHASE; MYELODYSPLASTIC SYNDROME; PHENOTYPE; SUPPRESSOR GENE;

AGED; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 5; CYTOGENETIC ANALYSIS; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOCYTIC, ACUTE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES;

EID: 2942720402     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Van den Berghe H, Michaux L. 5q-, twenty-five years later: a synopsis. Cancer Genet Cytogenet 1997;94:1-7.
2. Washington LBT, Doherty D, Glassman A, Martins J, Ibrahim S, Lai R. Myeloid disorders with deletion of 5q as the sole karyotypic abnormality: the clinical and pathologic spectrum. Leuk Lymphoma 2002;43:761-5.
3. Lindvall C, Nordenskjold M, Porwit A, Bjorkholm M, Blennow E. Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements. Haematologica 2001;86:1158-64.
4. Mitelman Database of chromosome Aberrations in Cancer (2000) Mitelman F, Johansson B, Mertens F, eds. http://cgap.nci.nih.gov/Chromosome/Mitelman.
5. Christiansen DH, Andersen MK, Pedersen-Bjergaard J. Mutation with loss of heterozygosity of p53 are common in the related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis. J Clin Oncol 2001;19:1405-13.
6. Crescenzi B, Fizzotti M, Piattoni S, La Starza R, Matteucci C, Carotti A, et al. Interphase FISH for Y chromosome, VNTR polymorphisms, and RT-PCR for BCR-ABL in the monitoring of HLA-matched and mismatched transplants. Cancer Genet Cytogenet 2000;120:25.
7. Dierlamm J, Wlodarska I, Michaux L, La Starza R, Zeller W, Mecucci C, et al. Succesful use of the same slide for consecutive fluorescence in situ hybridization (FISH) experiments. Genes Chromosomes Cancer 1996;16:261-4.
8. Lai JL, Preudhomme C, Zandecki M, Flactif M, Vanrumbeke M, Lepelley P, et al. Myelodysplastic syndromes and acute myeloid leukemia with deletion. An entity characterized by specific dysgranulopoiesis and high incidence of P53 mutations. Leukemia 1995;9:370-81.
9. Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J, et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 2001;97:3581-8.
10. Godon C, Proffitt J, Dastugue N, Lafage-Pochitaloff M, Mozziconacci M-J, Talmant P, et al. Large deletion 5′ to the ETO breakpoint are recurrent events in patients with t(8;21) acute myeloid leukemia. Leukemia 2002;16:1752-4.
11. Preudhomme C, Vachee A, Quesnel B, Wattel E, Cosson A, Fenaux P. Rare occurrence of mutations of the FLR exon of the neurofibromatosis 1(NF1) gene in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Leukemia 1993;7:1071.
12. Lee YY, Kim WS, Bang YJ, Park S, Yoon WJ, Cho KS, et al. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia. Stem Cells 1995;13:556-63.
13. Borkhardt A, Brettreich S, Borkhardt AK, Repp R, Harbott J, Kreuder J, et al. Low frequency of RAS gene mutations and absence of mutations within the FLR exon of NF1 in patients with therapy-related leukemias. Leukemia 1995;9:1790-1.
14. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D, et al. Haploisufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukemia. Nat Genet 1999;23:166-75.
15. Ketterling R, Wyatt W, VanWier SA, Law M, Hodnefield JM, Hanson CA, et al. Primary myelodysplastic syndrome with normal cytogenetics: utility of "FISH panel testing" and M-FISH. Leuk Res 2002;26:235-40.
16. Dumortier A, Kirstetter P, Kastner P, Chan S. Ikaros regulates neutrophil differentiation. Blood 2003;101:2219-26.
17. Loeb LA, Loeb KR, Anderson JP. Multiple mutations and cancer. Proc Natl Acad Sci USA 2003;100:776-81.
18. Sloand E, Fuhrer M, Maciejewski JP, Johnson S, Barret AJ, Young NS. Preferential suppression of trisomy 8 versus normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Leuk Res 2003;Suppl 1:S79.